Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Stability of 0.5% cidofovir stored under various conditions for up to 6 months.

Stiles J, Gwin W, Pogranichniy R.

Vet Ophthalmol. 2010 Jul;13(4):275-7. doi: 10.1111/j.1463-5224.2010.00784.x.

PMID:
20618808
2.

Stability of cidofovir in 0.9% sodium chloride injection and in 5% dextrose injection.

Yuan LC, Samuels GJ, Visor GC.

Am J Health Syst Pharm. 1996 Aug 15;53(16):1939-43.

PMID:
8862207
3.

Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir.

Gordon YJ, Araullo-Cruz TP, Johnson YF, Romanowski EG, Kinchington PR.

Invest Ophthalmol Vis Sci. 1996 Dec;37(13):2774-8.

PMID:
8977495
4.

Stability of cidofovir in extemporaneously prepared syringes.

Hennere G, Havard L, Bonan B, Prognon P.

Am J Health Syst Pharm. 2005 Mar 1;62(5):506-9. No abstract available.

PMID:
15745914
5.
6.

In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature.

Nedergaard H, Vestergaard S, Jensen PT, Kristiansen MW, Jensen MB, Ostergaard PB, Norsell T, Bjerre J.

Clin Ther. 2008 Jul;30(7):1309-15.

PMID:
18691990
7.

Stability of ceftazidime in plastic syringes and glass vials under various storage conditions.

Stewart JT, Warren FW, Johnson SM, Fox JL, Mullaney J.

Am J Hosp Pharm. 1992 Nov;49(11):2765-8.

PMID:
1471643
9.

Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial.

André P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, Fontan JE.

Ann Pharmacother. 2005 Sep;39(9):1462-6. Epub 2005 Jun 28.

PMID:
15985470
10.

Stability of cidofovir in 0.9% sodium chloride injection for five days.

Ennis RD, Dahl TC.

Am J Health Syst Pharm. 1997 Oct 1;54(19):2204-6. No abstract available.

PMID:
9331442
11.

Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.

Friedrichs C, Neyts J, Gaspar G, De Clercq E, Wutzler P.

Antiviral Res. 2004 Jun;62(3):121-3.

PMID:
15130535
12.

Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats.

Fontenelle JP, Powell CC, Veir JK, Radecki SV, Lappin MR.

Am J Vet Res. 2008 Feb;69(2):289-93. doi: 10.2460/ajvr.69.2.289.

PMID:
18241028
14.

Potent inhibition of genital herpesvirus infection in goats by cidofovir.

Tempesta M, Camero M, Bellacicco AL, Tarsitano E, Crescenzo G, Thiry J, Martella V, Decaro N, Elia G, Neyts J, Thiry E, Buonavoglia C.

Antivir Ther. 2007;12(6):977-9.

PMID:
17926653
15.
16.

In vitro susceptibility of sea lion poxvirus to cidofovir.

Nollens HH, Gulland FM, Jacobson ER, Hernandez JA, Klein PA, Walsh MT, Condit RC.

Antiviral Res. 2008 Oct;80(1):77-80. doi: 10.1016/j.antiviral.2008.03.007. Epub 2008 Apr 28.

PMID:
18485494
17.

A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.

Lalezari J, Schacker T, Feinberg J, Gathe J, Lee S, Cheung T, Kramer F, Kessler H, Corey L, Drew WL, Boggs J, McGuire B, Jaffe HS, Safrin S.

J Infect Dis. 1997 Oct;176(4):892-8.

PMID:
9333146
18.

Anti-Xa stability of diluted enoxaparin for use in pediatrics.

Dager WE, Gosselin RC, King JH, Christensen CL, Owings JT, Larkin EC.

Ann Pharmacother. 2004 Apr;38(4):569-73. Epub 2004 Feb 24.

PMID:
14982984
19.

Development of herpes simplex virus disease in patients who are receiving cidofovir.

Wyles DL, Patel A, Madinger N, Bessesen M, Krause PR, Weinberg A.

Clin Infect Dis. 2005 Sep 1;41(5):676-80. Epub 2005 Jul 26.

PMID:
16080090
20.

Cidofovir: a new therapy for cytomegalovirus retinitis.

Lalezari JP.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14 Suppl 1:S22-6. Review.

PMID:
9058614

Supplemental Content

Support Center